W. Robert Bishop
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Protein Kinase Regulation and GTPase Signaling, Cancer-related Molecular Pathways, Melanoma and MAPK Pathways, Growth Hormone and Insulin-like Growth Factors, Neuroblastoma Research and Treatments
Most-Cited Works
- → Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells.(1986)987 cited
- → K- and N-Ras Are Geranylgeranylated in Cells Treated with Farnesyl Protein Transferase Inhibitors(1997)875 cited
- → Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors(2013)676 cited
- → Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway(2002)534 cited
- → Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson–Gilford progeria syndrome(2012)365 cited
- → Farnesyl Transferase Inhibitors Block the Farnesylation of CENP-E and CENP-F and Alter the Association of CENP-E with the Microtubules(2000)320 cited